Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

PrismaSate BGK2/0 Dialysis Solution for Continuous Renal Replacement Therapy

FDA Recall Z-2049-2016 · Posted 2016-06-24

Recall StatusTerminated
Product CodeKPO
Date Initiated2016-05-23
Date Terminated2017-03-28
Product Quantity10,054 units

Reason for Recall

Presence of leaks near top of the PrismaSate bags

Firm Action

Baxter Healthcare Corporation sent an Urgent Product Recall communication to affected customers via U.S.P.S. first class mail on 05/23/2016.

Root Cause

Other

Distribution Pattern

Distributed to Columbia and the following US states: AZ, CA, CO, DE, FL, GA, IA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WI

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑